S. Anderson

发表

Maximising the effect of combination HIV prevention through prioritisation of the people and places in greatest need: a modelling study

T. Hallett, M. Dybul, D. Fecht, 2014, The Lancet.

Appraising the value of evidence generation activities: an HIV modelling study

J. Eaton, T. Hallett, P. Revill, 2018, BMJ Global Health.

How robust are the natural history parameters used in chlamydia transmission dynamic models? A systematic review

H. Ward, S. Anderson, K. Turner, 2014, Theoretical Biology and Medical Modelling.

Comparative Efficacy and Safety of Fostemsavir in Heavily Treatment-Experienced People With HIV-1.

S. Anderson, A. Clark, D. Browning, 2022, Clinical therapeutics.

Introducing optimism to models of resource allocation to reduce HIV incidence - Authors' reply.

T. Hallett, J. McGillen, S. Anderson, 2017, The lancet. HIV.

Frontloading HIV financing maximizes the achievable impact of HIV prevention

T. Hallett, P. Ghys, S. Anderson, 2018, Journal of the International AIDS Society.

HIV prevention where it is needed most: comparison of strategies for the geographical allocation of interventions

Timothy B Hallett, Sarah-Jane Anderson, T. Hallett, 2017, Journal of the International AIDS Society.

Patient-Reported Outcomes in the Phase III BRIGHTE Trial of the HIV-1 Attachment Inhibitor Prodrug Fostemsavir in Heavily Treatment-Experienced Individuals

D. Cella, M. Murray, S. Anderson, 2021, The Patient - Patient-Centered Outcomes Research.

Cost-effectiveness of the long-acting regimen cabotegravir plus rilpivirine for the treatment of HIV-1 and its potential impact on adherence and viral transmission: A modelling study

S. Anderson, T. Ward, D. Becker, 2021, PloS one.

Global implementation of PrEP as part of combination HIV prevention – Unsolved challenges

S. Delany-Moretlwe, S. McCormack, T. Hallett, 2016 .

Estimating HIV Management and Comorbidity Costs Among Aging HIV Patients in the United States: A Systematic Review

P. McEwan, S. Anderson, A. Oglesby, 2020, Journal of managed care & specialty pharmacy.

Maximising the Impact of Combination HIV Prevention through Prioritising the People and Places in Greatest Need

T. Hallett, M. Dybul, D. Fecht, 2014 .

PrEP as a feature in the optimal landscape of combination HIV prevention in sub-Saharan Africa

T. Hallett, J. McGillen, S. Anderson, 2016, Journal of the International AIDS Society.

Maximising HIV prevention by balancing the opportunities of today with the promises of tomorrow: a modelling study

T. Hallett, G. Garnett, K. Harris, 2016, The lancet. HIV.

Optimum resource allocation to reduce HIV incidence across sub-Saharan Africa: a mathematical modelling study.

T. Hallett, M. Dybul, J. McGillen, 2016, The lancet. HIV.

Cost-Effectiveness of Juluca (dolutegravir/rilpivirine) for Human Immunodeficiency Virus (HIV-1) Infection Treatment in Virologically Suppressed Adults in Taiwan.

S. Anderson, N. Ko, Chiung-yuan Hsu, 2021, Value in health regional issues.

Spatial patterns of HIV prevalence and service use in East Zimbabwe: implications for future targeting of interventions

S. Gregson, S. Anderson, C. Nyamukapa, 2017, Journal of the International AIDS Society.

The importance of local epidemic conditions in monitoring progress towards HIV epidemic control in Kenya: a modelling study

T. Hallett, G. Garnett, S. Anderson, 2018, Journal of the International AIDS Society.

Cost-effectiveness and budget impact of dolutegravir/lamivudine for treatment of human immunodeficiency virus (HIV-1) infection in the United States

S. Anderson, A. Oglesby, L. Evitt, 2021, Journal of managed care & specialty pharmacy.

Evaluation of geospatial methods to generate subnational HIV prevalence estimates for local level planning The Subnational Estimates Working Group of the HIV Modelling Consortium M

S. Anderson, 2016 .

Optimal resource allocation to reduce HIV incidence across sub-Saharan Africa: a mathematical modelling study

T. Hallett, M. Dybul, J. McGillen, 2016 .